BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 33946043)

  • 21. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of potential key genes in very early hepatocellular carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
    World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis.
    Chen Z; Chen J; Huang X; Wu Y; Huang K; Xu W; Xie L; Zhang X; Liu H
    J Comput Biol; 2019 May; 26(5):485-494. PubMed ID: 30864827
    [No Abstract]   [Full Text] [Related]  

  • 24. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S
    Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
    Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
    Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
    Cheng Y; Ping J; Chen J
    Pathol Oncol Res; 2018 Jul; 24(3):507-514. PubMed ID: 28669080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
    Yu Z; Ma X; Zhang W; Chang X; An L; Niu M; Chen Y; Sun C; Yang Y
    Biomed Res Int; 2021; 2021():1093702. PubMed ID: 33564675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
    Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma.
    Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Shi N; Jin H
    J Clin Lab Anal; 2021 Nov; 35(11):e24005. PubMed ID: 34523732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Key Biological Processes, Pathways, Networks, and Genes with Potential Prognostic Values in Hepatocellular Carcinoma Using a Bioinformatics Approach.
    Lu H; Zhu Q
    Cancer Biother Radiopharm; 2021 Dec; 36(10):837-849. PubMed ID: 32598174
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma.
    Li L; Xia S; Shi X; Chen X; Shang D
    Sci Rep; 2021 May; 11(1):10728. PubMed ID: 34021184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma.
    Shi L; Shang X; Nie K; Lin Z; Zheng M; Wang M; Yuan H; Zhu Z
    J Clin Pathol; 2021 Aug; 74(8):504-512. PubMed ID: 33004423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients.
    Huo X; Qi J; Huang K; Bu S; Yao W; Chen Y; Nie J
    BMC Cancer; 2020 Aug; 20(1):771. PubMed ID: 32807131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
    Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q
    Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549
    [No Abstract]   [Full Text] [Related]  

  • 40. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.